VivoSim Labs, Inc.
Biotechnology
Healthcare
VIVS
2.50 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.72
52 week high
15.24
high
4.05
52 week low
0.00
low
3.72
growth
-36.50 %
previous Close
3.72
P/E ratio
-3
market cap
5.15 M
div yield
0
usd
Jun 2025
qoq
revenue
37.00 K
-27.45 %
net incoming
-2.84 M
-141.49 %
eps
-1.14 %
-131.45 %
eps surprise
0.00 %
net profit margin
-7683.78 %
-21119.00 %
operating incoming
-2.92 M
7.58 %
net change in cash
-2.26 M
-122.23 %
cash on hand
9.06 M
-19.95 %
cost of revenue
0.00 %
top top